READING, 9th October 2006 – Archimedes Pharma today announces additional expansion of its management team to support its maturing pipeline. A Director of Regulatory Affairs and Supply Chain Manager have been recruited to complete the team managing the development of Archimedes’ lead product, Nasalfent™, through Phase III trials and also to augment the company’s capabilities to add value to in-licensed and other acquisition candidates.
